February 8, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Global Glaucoma Treatment Market over the trend period from 2014 to 2019 and the forecast period from 2020 to 2026. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Global Glaucoma Treatment Market Overview:

The Global Glaucoma Treatment Market is projected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over 7.4% during the forecast period.
  
What is Glaucoma?

Glaucoma is primarily referred to as a silent thief of sight, as most of its types typically exhibit no symptoms, and no pain until noticeable vision loss occurs. It is a group of related eye disorders that occurs mainly due to damage to the optic nerve which carries information from the eye to the brain. In most cases, associated with ocular hypertension, a condition when the pressure inside the eye is higher than normal pressure but sometimes it can occur when the intraocular pressure is normal.

Key Players

Key players operating in the global glaucoma treatment market are-
• Merck & Co., Inc. (The U.S),
• Novartis AG (Switzerland), Allergan Plc (The U.S),
• AERIE PHARMACEUTICALS, INC. (The U.S),
• Bausch & Lomb Incorporated (The U.S),
• Akorn, Incorporated (The U.S),
• Pfizer Inc (The U.S),
• Inotek Pharmaceuticals (The U.S), and
• Santen Pharmaceutical Co., Ltd.(Japan).

The Global Glaucoma Treatment Market is segmented by–

• By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
• By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
• By Distribution Channel (Hospital, Retail, Online)
• By Region

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/1711/glaucoma-treatment-market.html#for

Regional analysis:

By region, the North American market witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
• This can be attributed to rising healthcare expenditure, the presence of major healthcare companies, and the increasing senior population, promulgating the product region in the region.
• Moreover, growing cases of glaucoma in the region coupled with better healthcare infrastructure further boost regional growth.

About Stratview Research
Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176